ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Jacksonville, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Breast Cancer
Carcinoma
Endometrial Cancer
Ovarian Cancer
Neoplasm Metastasis

Prostate Cancer trials near Jacksonville, FL, USA:

Locations recently updated

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate ...

Enrolling
Castration Resistant Prostatic Cancer
Metastatic Castration-resistant Prostate Cancer
Biological: JANX007
Drug: Darolutamide

Phase 1

Janux Therapeutics

Jacksonville, Florida, United States and 31 other locations

with prostate cancer who received at least one dose of AAA617 from interventional, Phase I-IV Novartis sponsored clinical trials....

Enrolling
Prostate Cancer
Drug: AAA617

Phase 4

Novartis
Novartis

Jacksonville, Florida, United States and 53 other locations

of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate...

Active, not recruiting
Prostate Cancer
Device: Vanquish System
Francis Medical

Jacksonville, Florida, United States and 25 other locations

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...

Active, not recruiting
Prostatic Neoplasms
Drug: Apalutamide
Drug: Placebo

Phase 3

Aragon Pharmaceuticals

Jacksonville, Florida, United States and 378 other locations

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...

Enrolling
Prostate Cancer
Drug: prednisone
Drug: Leuprolide acetate

Phase 2

Astellas
Astellas

Jacksonville, Florida, United States and 235 other locations

The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.

Enrolling
Prostatic Neoplasms
Prostate Cancer
Drug: 64Cu-SAR-bisPSMA

Phase 3

Clarity Pharmaceuticals

Jacksonville, Florida, United States and 22 other locations

of tulmimetostat (DZR123) and JSB462 (luxdegalutamide) versus standard of care in participants with progressive metastatic castrate resistant prostate...

Enrolling
Progressive Metastatic Castrate Resistant Prostate Cancer
Drug: Tulmimetostat RP2D QD
Drug: JSB462 QD

Phase 1, Phase 2

Novartis
Novartis

Jacksonville, Florida, United States and 4 other locations

Researchers are looking for a better way to treat men at high-risk of biochemical recurrence (BCR) of prostate cancer.BCR means tha ...

Enrolling
Biochemically Recurrent Prostate Cancer
Other: Placebo matching darolutamide
Drug: Darolutamide (BAY1841788, Nubeqa)

Phase 3

Bayer
Bayer

Jacksonville, Florida, United States and 305 other locations

prednisone in treating patients with castration-resistant metastatic prostate cancer. Androgens can cause the growth of prostate...

Active, not recruiting
Hormone-resistant Prostate Cancer
Stage IV Prostate Cancer
Drug: prednisone
Drug: abiraterone

Phase 3

Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology

Jacksonville, Florida, United States and 538 other locations

vipivotide tetraxetan (AAA617) in participants with oligometastatic prostate cancer (OMPC) progressing after definitive therapy to ...

Enrolling
Oligometastatic Prostate Cancer (OMPC)
Drug: AAA617

Phase 3

Novartis
Novartis

Jacksonville, Florida, United States and 133 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems